# CLE vs. ROSE for Ex Vivo Lung Biopsy Assessment

> **NCT07725510** · — · RECRUITING · sponsor: **Guangzhou Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Peripheral Pulmonary Lesions (PPLs)

## Interventions

- **DIAGNOSTIC_TEST:** Ex Vivo Confocal Laser Endomicroscopy (CLE) Imaging and Interpretation
- **DIAGNOSTIC_TEST:** Rapid On-Site Evaluation (ROSE) Imaging and Interpretation

## Key facts

- **NCT ID:** NCT07725510
- **Lead sponsor:** Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725510, "CLE vs. ROSE for Ex Vivo Lung Biopsy Assessment". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*